NCT02675829 2026-03-04Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting131 enrolled
NCT04544748 2024-03-06A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesAO GENERIUMPhase 1 Active not recruiting48 enrolled